MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Author MStranslate

MStranslate

haemoglobin

Haemoglobin as Source of Iron Deposits in MS

MStranslate
December 14, 2016
Research
Iron deposits in the brain can be toxic and they have been suggested to be a possible cause of the damage seen in multiple sclerosis (MS). New research from Imperial College London (UCL) has shed more light...
MS Many Stories

MS: Many Stories – From the MStranslate Community

MStranslate
December 5, 2016
Community, MS: Many Stories
Whilst many people realise that exercise has benefits for people with multiple sclerosis (MS), they often don't know where to begin.  In this new instalment of our MS: Many Stories series, we meet Andrew,...
Epstein-Barr Virus

MS & Epstein-Barr Virus Update – Part 2

MStranslate
November 24, 2016
Epstein-Barr virus, Infection, Research, Understanding Science
Research Summary: EBV Infection and Multiple Sclerosis: Lessons from a Marmoset Model Earlier in the week, we discussed the background information about the potential role of Epstein-Barr Virus (EBV) and...
Epstein-Barr Virus

MS & Epstein-Barr Virus Update – Part 1

MStranslate
November 21, 2016
Epstein-Barr virus, Infection, Research, Understanding Science
3 Comments
Today, we are presenting Part 1 of a two-part update on a role for Epstein-Barr Virus (EBV) in multiple sclerosis (MS).  This first part is going to focus on the evidence of why people think that a link may...
MitoQ

MitoQ & Mitochondrial Dysfunction in MS

MStranslate
November 12, 2016
Research
Research Summary: MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis The...
MS Many Stories

MS: Many Stories – From the MStranslate Community

MStranslate
October 27, 2016
MS: Many Stories
Our latest MS: Many Stories feature has been submitted by a regular MStranslate contributor that would like to remain anonymous.  The article was inspired by a recent visit to the neurologist and is called...
Monoclonal Antibodies

Monoclonal Antibodies for MS Treatments

MStranslate
October 20, 2016
Research, Understanding Science
By Brett Drummond What’s in a name? I was recently asked a question:  “Why do all of the new MS drugs end in mab?  Does that mean something?”.  The answer is yes and it’s probably worth...
MS Many Stories

MS: Many Stories – From the MStranslate Community

MStranslate
October 12, 2016
Community, MS: Many Stories
1 Comment
Our latest MS: Many Stories feature is the second instalment in a series being written by Toni, a regular MStranslate contributor and member of our local MS community here in Melbourne, Australia.  To...
MS progression

Rates of MS Progression: Dr Tomas Kalincik (MSBase)

MStranslate
October 11, 2016
Q&A, Research
Upon his return from ECTRIMS 2016, Dr Tomas Kalincik from the Melbourne Brain Centre at Royal Melbourne Hospital spoke to MStranslate about recently published research by MSBase investigators.  Their...
Clinically Stable MS

Clinically Stable MS & Magnetic Resonance Imaging

MStranslate
October 3, 2016
Neuroimaging, Research
What is clinically stable multiple sclerosis? As most of you might be aware, the most common form of multiple sclerosis is relapsing-remitting MS (RRMS).  In RRMS, people may go through periods of attacks...
  1. 17
  2. 18
  3. 19
  4. 20
  5. 21
  6. 22
  7. 23

Posts

  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.